| 期刊全称 | Journal of Applied Clinical Medical Physics | ||||||||||||||||||||||||||||||||||||
| 期刊缩写 | J. Appl. Clin. Med. Phys. | ||||||||||||||||||||||||||||||||||||
|
涉及主题
（科研通AI识别） |
|||||||||||||||||||||||||||||||||||||
| 期刊介绍 | Journal of Applied Clinical Medical Physics is an international Open Access publication dedicated to clinical medical physics. JACMP welcomes original contributions dealing with all aspects of medical physics from scientists working in the clinical medical physics around the world. JACMP accepts only online submission. JACMP will publish: -Original Contributions: Peer-reviewed, investigations that represent new and significant contributions to the field. Recommended word count: up to 7500. -Review Articles: Reviews of major areas or sub-areas in the field of clinical medical physics. These articles may be of any length and are peer reviewed. -Technical Notes: These should be no longer than 3000 words, including key references. -Letters to the Editor: Comments on papers published in JACMP or on any other matters of interest to clinical medical physics. These should not be more than 1250 (including the literature) and their publication is only based on the decision of the editor, who occasionally asks experts on the merit of the contents. -Book Reviews: The editorial office solicits Book Reviews. -Announcements of Forthcoming Meetings: The Editor may provide notice of forthcoming meetings, course offerings, and other events relevant to clinical medical physics. -Parallel Opposed Editorial: We welcome topics relevant to clinical practice and medical physics profession. The contents can be controversial debate or opposed aspects of an issue. One author argues for the position and the other against. Each side of the debate contains an opening statement up to 800 words, followed by a rebuttal up to 500 words. Readers interested in participating in this series should contact the moderator with a proposed title and a short description of the topic | ||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||
| 期刊ISSN | print: 1526-9914 | ||||||||||||||||||||||||||||||||||||
| 2023最新影响因子 (2024年6月20日公布) 与上一年的差值 |
2↓ 0.1 | ||||||||||||||||||||||||||||||||||||
| 历年影响因子 |
|
||||||||||||||||||||||||||||||||||||
| 历年发表/被引量 （科研通AI通过大数据分析） |
|
||||||||||||||||||||||||||||||||||||
| h-index（2021） | 41 | ||||||||||||||||||||||||||||||||||||
| 自引率 | 15.00% | ||||||||||||||||||||||||||||||||||||
| 涉及的研究领域 | 医学-核医学 | ||||||||||||||||||||||||||||||||||||
| WOS期刊分区 （2024年6月20日公布） |
JCR学科分类
JCI学科分类
|
||||||||||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （2023年12月升级版） |
|
||||||||||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （2022年12月升级版） |
|
||||||||||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （2021年12月基础版） |
|
||||||||||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （2021年12月升级版） |
|
||||||||||||||||||||||||||||||||||||
| 中科院《国际期刊预警名单（试行）》名单 |
2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2021年01月发布的2020版：不在预警名单中 |
||||||||||||||||||||||||||||||||||||
| 期刊主页 |
（系统检测到多个链接，仅供参考，如有错误，请通过页面底部反馈） |
||||||||||||||||||||||||||||||||||||
| 投稿网址 | http://www.jacmp.org/index.php/jacmp/about/submissions#onlineSubmissions | ||||||||||||||||||||||||||||||||||||
| 编辑部地址 | MULTIMED INC, 66 MARTIN ST, TORONTO, CANADA, ON, L9T 2R2 | ||||||||||||||||||||||||||||||||||||
| 出版商 | American Institute of Physics | ||||||||||||||||||||||||||||||||||||
| 出版国家（地区） | UNITED STATES | ||||||||||||||||||||||||||||||||||||
| 出版语言 | English | ||||||||||||||||||||||||||||||||||||
| 出版周期 | Quarterly | ||||||||||||||||||||||||||||||||||||
| 创刊年份 | 2000 | ||||||||||||||||||||||||||||||||||||
| 每年出版文章数 | 324 | ||||||||||||||||||||||||||||||||||||
| Gold OA文章占比 | 69.71% | ||||||||||||||||||||||||||||||||||||
| 原创研究文献占比 （排除综述） |
97.33% | ||||||||||||||||||||||||||||||||||||
| SCI收录类型 |
Science Citation Index Expanded (SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) |
||||||||||||||||||||||||||||||||||||
| PubMed链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1526-9914%5BISSN%5D | ||||||||||||||||||||||||||||||||||||
| 平均审稿周期 | 网友分享经验： 平均3月 |
||||||||||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 约75% |
||||||||||||||||||||||||||||||||||||
| 相关链接 |
您可以在上述网站查看该期刊的网友互动，及期刊影响力的其它指标。
|
||||||||||||||||||||||||||||||||||||
皖公网安备34019202002308
